Sodium cromoglicate + ibuprofen combination regimen - AZTherapies

Drug Profile

Sodium cromoglicate + ibuprofen combination regimen - AZTherapies

Alternative Names: ALZT OP1; ALZTOP1a + ALZTOP1b; Ibuprofen + cromolyn; Ibuprofen + sodium cromoglicate

Latest Information Update: 02 Feb 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator AZTherapies
  • Class Antiallergics; Benzopyrans; Chromones; Phenylpropionates; Small molecules
  • Mechanism of Action Amyloid beta-protein inhibitors; Inflammation mediator inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Alzheimer's disease

Most Recent Events

  • 31 Jan 2018 Pharmacodynamics data from a preclinical trial in Alzheimer's disease released by AZTherapies
  • 15 Sep 2015 AZTherapies receives Special Protocol Assessment agreement for a pivotal phase III trial in Alzheimer's disease from US FDA
  • 15 Sep 2015 AZTherapies plans a phase III trial in Alzheimer's disease in USA and other countries
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top